Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder / Huirong Zheng en European Neuropsychopharmacology, Año 2019 - Vol. 29 - No. 3 (Marzo)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2019 - Vol. 29 - No. 3 (Marzo) . - pp. 397-404 Título : Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder : A randomized double-blind, placebo-controlled study Tipo de documento: texto impreso Autores: Huirong Zheng, Autor ; Fujun Jia, Autor ; Hongying Han, Autor Fecha de publicación: 2021 Artículo en la página: pp. 397-404 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno obsesivo compulsivo refractario al tratamiento, Metilfenidato (MPH) de formulaciones de liberación prolongada (MPH-ER), Aumento Resumen: More effective, tolerable interventions for treatment-refractory obsessive-compulsive disorder (OCD) are needed. Preliminary findings encourage optimism that methylphenidate augmentation may be of benefit in the treatment of OCD. Link: ./index.php?lvl=notice_display&id=26353 [artículo] Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder : A randomized double-blind, placebo-controlled study [texto impreso] / Huirong Zheng, Autor ; Fujun Jia, Autor ; Hongying Han, Autor . - 2021 . - pp. 397-404. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2019 - Vol. 29 - No. 3 (Marzo) . - pp. 397-404 Palabras clave: Trastorno obsesivo compulsivo refractario al tratamiento, Metilfenidato (MPH) de formulaciones de liberación prolongada (MPH-ER), Aumento Resumen: More effective, tolerable interventions for treatment-refractory obsessive-compulsive disorder (OCD) are needed. Preliminary findings encourage optimism that methylphenidate augmentation may be of benefit in the treatment of OCD. Link: ./index.php?lvl=notice_display&id=26353

---

1 (1 - 1 / 1)